Literature DB >> 3704196

Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines.

R Håkanson, H Blom, E Carlsson, H Larsson, B Ryberg, F Sundler.   

Abstract

Hypo- or anacidity, caused by antisecretagogues, stimulates gastrin release and leads to hypergastrinaemia. If drug treatment is maintained over a period of time, the hypergastrinaemia can be expected to give rise to trophic effects. We examined the trophic consequences of the very marked hypergastrinaemia produced by long-term treatment (16-20 weeks) of rats with large doses of the substituted benzimidazole, omeprazole, a potent and long-acting blocker of acid secretion. The weight of the stomach and the oxyntic mucosal thickness were increased, whereas the weight of the pancreas and the intestines and the thickness of the mucosa of the antrum and small and large intestine were unaffected. The number of exocrine cells (parietal, zymogen and mucous cells) were uniformly increased by 25-30%. The density of parietal and zymogen cells, expressed as number of cell nuclei per mm2 epithelium, was unchanged. The volume density of parietal cells, expressed as % of epithelial volume, was also unchanged, implying that the volume of the individual parietal cell had not increased. The density of endocrine ECL cells in the stomach increased 5-fold. Thus, the findings demonstrate a growth-promoting effect of the hypergastrinaemia on the oxyntic mucosa, the ECL cells in particular, and the lack of such an effect on the antrum, pancreas and intestines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3704196     DOI: 10.1016/0167-0115(86)90041-8

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  31 in total

1.  Effects of gastric fundectomy and antrectomy on the exocrine pancreas in the hamster.

Authors:  M Chu; J F Rehfeld; K Borch
Journal:  Int J Pancreatol       Date:  1992-10

2.  Chronic omeprazole treatment increases duodenal susceptibility to ethanol injury in rats.

Authors:  R A Erickson; S Bezabah; G Jonas; E Lifrak; A S Tarnawski
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  Role of endogenous hypergastrinemia in regenerating endocrine pancreas after partial pancreatectomy.

Authors:  G Xu; S Sumi; M Koike; K Tanigawa; Y Nio; K Tamura
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 4.  Histamine H2-receptor antagonists versus prostaglandins in the treatment of peptic ulcer disease.

Authors:  J G Penston; K G Wormsley
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

5.  Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster.

Authors:  M Chu; E Kullman; J F Rehfeld; K Borch
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

6.  G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo.

Authors:  A Nagata; M Ito; N Iwata; J Kuno; H Takano; O Minowa; K Chihara; T Matsui; T Noda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 7.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

Review 8.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  The structure of bioactive analogs of the N-terminal region of gastrin-17.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Peptides       Date:  2009-09-18       Impact factor: 3.750

10.  Bioactivity of analogs of the N-terminal region of gastrin-17.

Authors:  Jeffrey Copps; Shawn Ahmed; Richard F Murphy; Sándor Lovas
Journal:  Peptides       Date:  2009-09-15       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.